Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort. Defymed is a spin-off of the Centre européen d’étude du Diabète (European center for diabetes studies), which began work on a bioartificial pancreas in 1996. Today, Defymed focuses on diabetes, which is considered to be one of the major epidemics of the 21st century.
- Develop innovative medical devices using breakthrough technologies,
- Conduct the preclinical and clinical research to confirm the proper operation and safety of these medical devices,
- Improve the quality of life of patients using physiological treatment solutions
The creation of medical devices at Defymed puts the patient at the center of our innovations at all times. Our enthusiasm and close teamwork are consequently dedicated to improving the quality of life of patients. Our various international partners support us in our goal of developing a medical device for the physiological treatment of patients.